A biosimilar is a biologic drug that is highly similar to an already-approved biologic drug. Biosimilars are typically less expensive than the original biologic. Medicare Part D plans may cover biosimilars at a lower tier than the original biologic, resulting in lower cost-sharing for you.
Key Points
- Biosimilar: highly similar to an already-approved biologic drug
- Typically less expensive than the original biologic
- Part D plans may cover biosimilars at a lower tier
- Lower tier = lower cost-sharing for you
- An independent agent can help you find plans that cover biosimilars at the lowest cost